Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Portable PET Scanner to Detect Earliest Stages of Alzheimer’s Disease

By HospiMedica International staff writers
Posted on 05 Nov 2024

During a positron emission tomography (PET) scan, a radioactive tracer is injected into the bloodstream, where it accumulates in the targeted tissue and emits signals that the PET scanner detects. More...

These signals are then converted into images. However, current PET scanners often suffer from low spatial resolution, which limits image quality and hinders the reliable quantification of biomarkers such as amyloid plaques and tau tangles—protein aggregates associated with Alzheimer’s disease. Researchers are now developing a portable, high-resolution PET scanner capable of detecting the early stages of Alzheimer’s disease.

This new PET scanner, being created by researchers at Weill Cornell Medicine (New York, NY, USA), features an upright design that allows patients to sit in a chair that moves with the unit, enhancing portability and accessibility. This innovation enables the scanner to be transported to medical centers lacking advanced brain imaging technologies, thereby extending high-quality care to a more diverse patient population. In a proof-of-concept study, the team developed the Prism-PET scanner, which boasts the highest resolution of any PET scanner to date. This device can identify "hot spots," or areas with elevated concentrations of the radioactive tracer, that are less than 1 mm in diameter when tested with brain phantoms, which mimic human tissue. In contrast, commercially available PET scanners produce images with considerably less detail.

The researchers plan to utilize Prism-PET to identify tau tangles in the transentorhinal cortex, a critical hub for memory, navigation, and temporal perception. This area is the first to show the presence of tau tangles, signaling the onset of Alzheimer’s disease even before the appearance of symptoms like mild cognitive impairment. To enhance imaging capabilities further, the scientists will refine motion compensation techniques to minimize blurring in PET images caused by patient movement. Following the FDA's 2023 approval of lecanemab, a monoclonal antibody that targets amyloid plaques and is currently the only treatment demonstrated to slow Alzheimer’s progression, the demand for PET imaging has surged. The scanner's compact design means that even community hospitals and other healthcare facilities do not require a dedicated space for brain PET imaging. Additionally, one possibility for meeting this demand includes using the scanner in a mobile unit, such as a truck, that can travel to underserved areas.

“Our overall goal is two-fold—having the highest performance brain PET scanner available, while also addressing its accessibility and portability to serve the community,” said Dr. Amir H. Goldan, associate professor of electrical engineering in radiology at Weill Cornell Medicine. “The earlier you can diagnose Alzheimer's disease, the better the chances of therapy being effective.”

Related Links:
Weill Cornell Medicine


Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Vessel Sealing Instrument
ERGOseal
Monitor/Defibrillator
Zenix
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image Credit: Adobe Stock

Emergency Department Campaign Reduces CT Use Without Identified Missed Injuries

Unnecessary head and cervical spine computed tomography (CT) in low-risk trauma patients exposes them to avoidable radiation, prolongs emergency department stays, and increases healthcare costs.... Read more

Surgical Techniques

view channel
Image: Researchers developed a handheld photothermal mid-infrared spectroscopic imaging (MIRSI) system that measures just 8 square inches. Probe light from a visible (red) diode laser and pump light from a modulated quantum cascade laser (QCL) are coupled into optical fibers and delivered to a flexible, handheld imager (blue dashed box). The beams are combined at a short-pass dichroic mirror and focused onto the sample using an off-axis parabolic mirror (OAP). (Image Credit:Rohith Reddy, University of Houston)

Handheld Infrared Imaging Device Supports Tumor Margin Assessment During Surgery

Accurately determining tumor margins during surgery remains challenging. Frozen-section pathology takes time and can miss residual disease, potentially leading to repeat surgery and delayed therapy.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.